Table 2. Patient acceptance of biosimilars.
Patient status: | Biologic-naïve | Bio-originator patient in need of switch for clinical reasons | Bio-originator patient not in need of switch for clinical reasons | |
---|---|---|---|---|
% patients accepted without reluctance | N | 24 | 24 | 24 |
Mean | 60.6 | 50.4 | 43.3 | |
SD | 27.8 | 27.9 | 27.5 | |
% patients reluctant but accepted as no other choice | N | 24 | 24 | 24 |
Mean | 21.0 | 25.6 | 29.4 | |
SD | 17.1 | 18.4 | 18.3 | |
% patients refused but accepted bio-originator | N | 24 | 24 | 24 |
Mean | 10.2 | 15.8 | 18.0 | |
SD | 11.3 | 17.9 | 14.4 | |
% patients refused biosimilar and bio-originator | N | 24 | 24 | 24 |
Mean | 8.1 | 8.1 | 9.3 | |
SD | 9.2 | 12.9 | 10.6 |
N, number of gastroenterologists responding; SD, standard deviation.